Tag: Guerbet
Intrasense: Guerbet takes a 39% stake
(CercleFinance.com) – Intrasense announces the entry into its capital of the Guerbet group up to 39% through a reserved capital increase for a total amount of 8.8 ME at an…
Guerbet: enters the capital of Intrasense up to 39%
(CercleFinance.com) – Intrasense announces the entry into its capital of the Guerbet group up to 39% through a reserved capital increase for a total amount of 8.8 ME at an…
Guerbet: formalizes the termination of its collaboration with Merative
(CercleFinance.com) – Guerbet announces that it has reached an agreement today with Merative terminating their collaboration signed in July 2018. This partnership aimed to design, develop and market software solutions…
Guerbet: Records the termination of its collaboration with Merative
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Guerbet: bright red after the warning
By Jean-Baptiste Andre Published on 2022-10-21 at 11:06 Photo credit © Guerbet (Boursier.com)…
Guerbet: news in pancreatic cancer
By Hector Chaunu Published on 09/26/2022 at 6:11 p.m. (Boursier.com) —…
A lackluster first half for Guerbet, unsurprisingly
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? Sale ? What course objective? Our experts engage and…
Guerbet: revenue down 1.3% in the 1st half – 07/21/2022 at 6:35 pm
(CercleFinance.com) – Guerbet announces revenue of €358.3 million at constant exchange rate (cc) for the 1st half, a figure down 1.3% compared to the same period a year earlier early.…
Guerbet: turnover down 1.3% in the 1st half
(CercleFinance.com) – Guerbet announces revenue of €358.3 million at constant exchange rate (cc) for the 1st half, a figure down 1.3% compared to the same period a year earlier early.…
Guerbet receives EMA approval for its Elucirem brand name – 06/13/2022 at 08:45
(AOF) – Guerbet has announced the approval by the European Medicines Agency (EMA) of its brand name Elucirem for Gadopiclenol. Gadopiclenol is an investigational gadolinium-based macrocyclic MRI contrast medium. Guerbet…
Abnormal volumes in today’s session: Cnp Assurances, Guerbet
During this trading session on Tuesday May 31, 2022, abnormal trading volumes were detected on the French market. Today, it is the Cnp Assurances share that stands out, with trading…
Guerbet: turnover disappoints, the share loses 4% – 04/22/2022 at 12:32
(CercleFinance.com) – Guerbet, a specialist in contrast products for medical imaging, reported on Friday quarterly sales below expectations, with production delays having notably penalized its sales in the United States.…